CoreFi Strategy, an upcoming publicly traded company, aims to simulate MicroStrategy's success in Bitcoin, but this time, ...
Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.
DeFi Technologies has announced plans to launch CoreFi Strategy, a new investment vehicle aimed at providing exposure to ...
DeFi Technologies has unveiled a new CoreFi Strategy that will offer investors a means to bet on Bitcoin in decentralized ...
DeFi Technologies launches CoreFi Strategy, offering regulated, leveraged Bitcoin yields through Core blockchain's BTCfi ...
Modeled after successful companies like MicroStrategy, CoreFi Strategy offers a leveraged, regulated approach to Bitcoin yield and CORE, Core blockchain's native asset, providing investors ...
CoreFi BTCfi strategy launches for leveraged Bitcoin gains, listing in Canada by 2025, inspired by MicroStrategy's investment ...